CASE REPORT Upper-Limb Disarticulation for Life-Threatening High-Flow Arteriovenous Malformation: Report of a Case by Su, Yi-Hsuan et al.
CASE REPORT
Upper-Limb Disarticulation for Life-Threatening
High-Flow Arteriovenous Malformation: Report of
aC a s e
Yi-Hsuan Su, MD, Vasu Karri, BSc(Hons), MRCS, MSc, Lai-Fan Lu, MD, and
Hung-Chi Chen, MD, FACS
Department of Plastic & Reconstructive Surgery, E-Da Hospital/I-Shou University, No 1 Yi-Da
Road, Jiau-Shu Village, Yan-Chao Township, Kaohsiung County, Taiwan, Republic of China
Correspondence: vakarri@gmail.com
Published December 22, 2010
Arteriovenous malformations (AVM) are high-ﬂow lesions having a direct connection
between an artery and vein, with bypass of the capillary bed.1 Those affecting the upper
limb and causing cardiac decompensation are rare.
Treatment of such lesions remains a surgical challenge. Despite multiple procedures,
total eradication is often not achieved. For some patients, limb amputation becomes neces-
sary and carries signiﬁcant risk.
We report a case of congenital AVM of the upper limb causing cardiac decompensa-
tion. The patient was safely and successfully treated by performing a 2-stage upper-limb
amputation.
CASE REPORT
A 32-year-old man presented with a congenital high-ﬂow AVM involving the left upper
limb and anterior chest (Fig 1). In recent years, the AVM had undergone rapid expansion
causing the patient signiﬁcant pain, high-output cardiac failure, and dyspnea on minimal
exertion. The pain was resolved by elevation of the arm.
Inaddition,therewasachronicallyinfectedwoundonthedorsumofthelefthandfrom
which he suffered a massive bleed 6 years previously. On that occasion, he lost 3500 mL
of blood. Amputation of the digits through the metacarpophalangeal joints had been pre-
viously performed at another hospital. At presentation, the left upper limb was warm and
hypertrophic with pulsating vessels. Bruits were audible and a thrill palpable over the ax-
illary artery. A dry eschar covered the chronic wound on the dorsum of the hand. The
vascular malformation over the anterior chest manifested as an uncomplicated reddened
patch.
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Figure 1. High-ﬂow arteriovenous malformation affecting the entire left upper limb.
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Figure 2. Magnetic resonance imaging revealed an extensive, diffuse arteriovenous malformation
involving all compartments of the upper limb. There was no skeletal hypertrophy.
Magnetic resonance imaging (MRI) was performed to determine extent of involved
tissues. This revealed an extensive diffuse AVM involving all compartments of the left up-
per limb. There was no skeletal hypertrophy (Fig 2). Selective embolization was discounted
for a number of reasons: the limb was nonfunctional; there was a risk of life-threatening
hemorrhage from the chronic wound; embolization would not obliterate the multiple nidi;
and partial excision following embolization would carry the risk of uncontrollable intraop-
erative bleeding, postoperative complications, and recurrence of the AVM. Hence, it was
decided at the outset to perform amputation of the affected upper limb. To minimize the
risk of uncontrollable intraoperative bleeding and wound-healing problems, amputation in
2 stages was planned.
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Figure 3. Ligation of the subclavian vessels (open wound) and placement of 2 rows of transcuta-
neous 1/0 PDS sutures. Skin was incised between these 2 rows of sutures.
The ﬁrst stage comprised disarticulation through the elbow. We intentionally avoided
amputation through bone to avoid the risk of uncontrollable bleeding from the bone end.
To minimize intraoperative bleeding, a tourniquet was inﬂated above the elbow and 1/0
PDS (Polydioxanone, Ethicon) transcutaneous sutures placed proximal to the incision.
The temporary sutures served to compress cutaneous and subcutaneous vessels thereby
reducing bleeding. Consequently, it became easier to formally transﬁx these vessels during
the amputation.
The second stage was performed 1 week later. Cardiovascular surgeons performed
ligation of left subclavian vessels (Fig 3), immediately followed by disarticulation through
the glenohumeral joint. Temporary transcutaneous sutures were used in a similar manner
as in the ﬁrst stage. Multiple, dilated vessels were encountered and ligated or transﬁxed.
Some of the vessels matched diameter of the aorta.
A fasciocutaneous ﬂap overlying the deltoid was raised and used for wound coverage.
A suction drain was inserted and a soft, bulky dressing applied. Postoperative recovery,
including wound healing, was unremarkable (Fig 4). The patient was discharged 2 weeks
later. Cardiac failure soon resolved. One-year postsurgery, the patient remains well and has
not encountered any wound problems.
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Figure 4. Uncomplicated recovery and normal wound healing.
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DISCUSSION
The management of AVM remains a signiﬁcant challenge, particularly those of the upper
limb. Intervention should only be contemplated when the lesion becomes symptomatic. A
variety of treatment strategies have been reported with varying success.2-5
Webelievethatplasticsurgeonsshouldbeanessentialmemberofthemultidisciplinary
team treating such lesions. In some instances, surgical resection of the AVM with maximal
preservation of upper-limb function may be required.
Clinical presentation of upper-limb AVMs can be diverse. Patients may suffer pain,
nerve compression, ulceration, hand dysfunction, and spontaneous bleeding.3,6,7 Shunting
through proximal arteriovenous ﬁstulae may result in distal steal phenomenon manifesting
as severe pain, ischaemia, and discoloration of the digits.5,9
Rarely, extensivearteriovenous shuntingmay lead to cardiac decompensation.8 This is
an absolute indication for surgery. The presence of an upper-limb AVM does not correlate
with vascular anomalies of other organ systems, nor does the pattern predict skeletal
overgrowth.5,9
Management of AVM varies, with a conservative approach adopted for patients that
are asymptomatic or have minor symptoms. If treatment is required, techniques that may
be used include catheter embolization or direct percutaneous sclerotherapy. Embolization
and sclerotherapy may be performed even after major surgery.
Surgical ligation of the main feeding vessels to the AVM often yields a poor result,
as a collateral circulation subsequently develops.10 In our patient, surgical ligation of the
subclavianvesselswasperformedaspartofthesecondstage.Thismeasurewasundertaken
to prevent uncontrollable bleeding during the shoulder disarticulation.
With the advent of highly selective embolization techniques, a number of authors have
reported safe and successful outcomes when treating AVM with this modality.6 Indeed, it
has been advocated as the treatment of choice by some.8
Regardless of the embolic agent used, the underlying aim is to obliterate the nidus.
However, embolotherapy must not be considered a deﬁnitive cure and can unintention-
ally worsen symptoms. Furthermore, repeat embolization may be necessary to deal with
recurrences.
In our patient, embolotherapy would not have been appropriate. The diffuse nature
of the AVM with multiple nidi wound render embolotherapy ineffective. Our patient
had a life-threatening, symptomatic, nonfunctional upper-limb AVM. In this situation,
we believe that amputation or disarticulation should be explained to the patient at the
outset. Amputation should be viewed as the “reconstructive” ﬁrst step in the patient’s
rehabilitation.
We favored glenohumeral disarticulation rather than amputation through the neck of
the humerus for a number of reasons. First, the latter provides no functional advantage,
as the patient cannot grip or stabilize large objects between the stump and thorax. Sec-
ond, even though the MRI indicated no apparent involvement of the humerus, amputation
through the bone may result in signiﬁcant bleeding. Third, the patient was not keen for
preservation of proximal humerus with associated soft tissue reconstruction. His concern
was a protracted postoperative stay and rehabilitation. The cosmetic deformity with gleno-
humeral disarticulation, however, is greater. Shoulder width and axillary contour are both
lost.
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Our rationale for a 2-stage amputation was based on the following: the aim of the ﬁrst
stage was to control the risk of bleeding and infection at the hand. Elbow disarticulation
could be easily performed as a tourniquet could be applied to the arm. After control of
infection, the second stage could be performed with the reduced risk of wound infection
and breakdown.
In one series of 33 patients with high-ﬂow AVM of the upper limb, the majority of
patients were treated by surgical excision.5 However, in patients with diffuse lesions, 9 of
10 patients required major amputation despite repeated excision and reconstruction. White
et al reported similar results, with 2 of 4 patients with high-ﬂow diffuse AVM of the entire
upper limb requiring amputation.4 Dickey et al also reported a 28% complication rate in
all patients with high-ﬂow lesions that underwent treatment.
A multidisciplinary approach is central to the effective management of AVMs. These
lesions are complex and difﬁcult to treat. Despite advances in embolic agents and micro-
catheter techniques, outcomes for high-ﬂow upper-limb AVM is far from satisfactory. For
diffuse lesions that are life-threatening, amputation as the ﬁrst step in the patient’s reha-
bilitation may be appropriate. Indeed, it has been previously stated that amputation was
unnecessarily delayed in such patients.5
Surgical excision must be performed in a systematic manner, involving steps to min-
imize the risk of uncontrollable intraoperative bleeding and postoperative complications.
In this case, successful amputation was achieved using temporary transcutaneous sutures
to control bleeding from skin edges, ligation of the subclavian vessels, and glenohumeral
disarticulation.
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